Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

10/22/18 SH -- HOSPIRA carpuject issue - Labetalol 20 mg-4 mL Syringe

From: Steven Higginbotham
Sent: 22 October, 2018 03:07 PM
To: Pharmacy
Subject: HOSPIRA carpuject issue - Labetalol 20 mg-4 mL Syringe
Attachment: DHCP Carpuject Letter                   Labetalol
 
Please see the attached photo and letter about an issue with Hospira carpuject syringes. Since there is a national shortage of IV labetalol, we are going to start repackaging these labetalol syringes with a filter needle so that we can use them at HH Main. A PULSE page announcement will be posted later today or tomorrow.

This is the same issue that we had with hydromorphone back in July/August.  

Let me know if you have any questions.

Thanks,
Steven
--
Steven Higginbotham, Pharm.D.
Supervisor, Central Pharmacy






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved